Back to Newsroom
Back to Newsroom

Healthcare Trade Setups to Win -- Teva Pharma Industries, Endo Intl., Impax Laboratories, and Retrophin

Friday, 12 February 2016 08:30 AM

ValuableInvestment.com

Topic:

NEW YORK, NY / ACCESSWIRE / February 12, 2016 / What a time to be shopping for value in the equity markets! The broad market sell-off has created a bin of great names at attractive prices, and given the right trade setup this could produce better-than-expected returns. Take a moment to sign up with us at http://valuableinvestment.com and find out what strategy could make you a fortune in healthcare.

We have also uncovered a billion dollar stock idea for 2016 and it is only the first quarter of the year! The management team behind this company has a track record of producing winning Ventures that literally go supernova, and now they have taken on this brand new biotech set to make history. Click on the link below to get the info right now!

http://valuableinvestment.com

ValuableInvestment.com trade alerts for today covers these potentially profitable equities in the Healthcare sector: Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International PLC (NASDAQ: ENDP), Impax Laboratories Inc. (NASDAQ: IPXL), and Retrophin Inc. (NASDAQ: RTRX). Shareholders of these companies can activate our free trading alerts and access the complimentary reports at:

http://valuableinvestment.com/Reports&Alerts-Activation

Teva Pharmaceutical Industries Ltd's stock declined 4.97%, to close the day at $54.08. The stock recorded a trading volume of 9.29 million shares, much above its three months average volume of 5.95 million shares. The company's shares are trading 12.96% below their 200-day moving average. Additionally, Teva Pharmaceutical Industries Ltd traded at a PE ratio of 26.25 and has a Relative Strength Index (RSI) of 24.73. Do not lose out on any TEVA's trade by activating your free access to the trade alerts now at:

http://valuableinvestment.com/TEVA

On Thursday, shares in Endo International PLC recorded a trading volume of 6.32 million shares, higher than their three months average volume of 3.72 million shares. The stock ended the day 4.92% lower at $48.49. The company is trading below its 50-day and 200-day moving averages by 16.18% and 32.04%, respectively. Furthermore, shares of Endo International PLC have an RSI of 33.69. Sign up for your trade alert on ENDP at:

http://valuableinvestment.com/ENDP

Impax Laboratories Inc.'s stock finished Thursday's session 4.51% lower at $30.73. A total of 0.67 million shares were traded, which was close to its three months average volume of 0.68 million shares. The company's shares are trading below their 50-day and 200-day moving averages by 23.30% and 28.16%, respectively. Impax Laboratories Inc.'s stock traded at a PE ratio of 83.05 and has an RSI of 21.69. Register for free on ValuableInvestment.com and activate your trade alert on IPXL at:

http://valuableinvestment.com/IPXL

On Thursday, shares in Retrophin Inc. ended the session 2.42% higher at $13.97. The stock reported a trading volume of 0.55 million shares, above its three months average volume of 0.51 million shares. Shares of the company traded at a PE ratio of 7.55. Retrophin Inc.'s shares have advanced 6.07% in the last one year, but the stock has declined 22.17% in the last one month. The company is trading 23.79% below its 50-day moving average and 43.11% below its 200-day moving average. Moreover, shares of Retrophin Inc. have an RSI of 32.10. Trade Alert on RTRX is available for free at:

http://valuableinvestment.com/RTRX

--

About ValuableInvestment.com:

Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com

RESTRICTIONS

ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: [email protected]

SOURCE: ValuableInvestment.com

Topic:
Back to newsroom
Back to Newsroom
Share by: